| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of postsynaptic actin cytoskeleton | 5.71e-13 | 11 | 159 | 7 | GO:0098973 | |
| GeneOntologyMolecularFunction | structural constituent of postsynapse | 5.06e-09 | 32 | 159 | 7 | GO:0099186 | |
| GeneOntologyMolecularFunction | structural constituent of synapse | 3.80e-08 | 42 | 159 | 7 | GO:0098918 | |
| GeneOntologyMolecularFunction | chondroitin sulfotransferase activity | 9.74e-06 | 6 | 159 | 3 | GO:0034481 | |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 8.28e-05 | 130 | 159 | 7 | GO:0005200 | |
| GeneOntologyMolecularFunction | chondroitin 4-sulfotransferase activity | 3.74e-04 | 4 | 159 | 2 | GO:0047756 | |
| GeneOntologyMolecularFunction | kinase activity | PDGFRA NEK10 ADCK5 BCKDK DGKG TRRAP PRAG1 MAP3K1 CCNE1 TGFBR3 PASK TBCK MAST1 PRKDC PKN3 NLK | 4.05e-04 | 764 | 159 | 16 | GO:0016301 |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | PDGFRA NEK10 ADCK5 BCKDK DGKG TRRAP PRAG1 MAP3K1 CCNE1 TGFBR3 PASK PARP10 TBCK MAST1 PRKDC POLQ PKN3 NLK | 4.97e-04 | 938 | 159 | 18 | GO:0016772 |
| GeneOntologyBiologicalProcess | postsynaptic actin cytoskeleton organization | 2.92e-09 | 31 | 157 | 7 | GO:0098974 | |
| GeneOntologyBiologicalProcess | postsynaptic cytoskeleton organization | 7.28e-09 | 35 | 157 | 7 | GO:0099188 | |
| GeneOntologyBiologicalProcess | regulation of protein kinase C signaling | 1.42e-05 | 20 | 157 | 4 | GO:0090036 | |
| GeneOntologyBiologicalProcess | protein kinase C signaling | 1.44e-05 | 41 | 157 | 5 | GO:0070528 | |
| GeneOntologyBiologicalProcess | regulation of kainate selective glutamate receptor activity | 5.76e-05 | 2 | 157 | 2 | GO:2000312 | |
| GeneOntologyBiologicalProcess | positive regulation of protein kinase C signaling | 6.83e-05 | 11 | 157 | 3 | GO:0090037 | |
| GeneOntologyCellularComponent | H4 histone acetyltransferase complex | POTEF ACTBL2 ACTB ACTG1 POTEKP TRRAP POTEE KANSL1 EPC1 POTEI | 1.49e-12 | 45 | 162 | 10 | GO:1902562 |
| GeneOntologyCellularComponent | NuA4 histone acetyltransferase complex | 1.94e-12 | 32 | 162 | 9 | GO:0035267 | |
| GeneOntologyCellularComponent | H4/H2A histone acetyltransferase complex | 1.94e-12 | 32 | 162 | 9 | GO:0043189 | |
| GeneOntologyCellularComponent | histone acetyltransferase complex | POTEF ACTBL2 ACTB ACTG1 POTEKP TRRAP POTEE KANSL1 EPC1 POTEI | 3.06e-09 | 94 | 162 | 10 | GO:0000123 |
| GeneOntologyCellularComponent | protein acetyltransferase complex | POTEF ACTBL2 ACTB ACTG1 POTEKP TRRAP POTEE KANSL1 EPC1 POTEI | 8.25e-09 | 104 | 162 | 10 | GO:0031248 |
| GeneOntologyCellularComponent | acetyltransferase complex | POTEF ACTBL2 ACTB ACTG1 POTEKP TRRAP POTEE KANSL1 EPC1 POTEI | 1.30e-08 | 109 | 162 | 10 | GO:1902493 |
| GeneOntologyCellularComponent | actin filament | POTEF ACTBL2 ACTB ACTG1 POTEKP CORO1B MAP3K1 IQGAP1 POTEE POTEI | 2.12e-07 | 146 | 162 | 10 | GO:0005884 |
| GeneOntologyCellularComponent | axon | KLHL24 HDAC6 TRPA1 PDGFRA POTEF ACTBL2 KATNB1 ACTB ACTG1 POTEKP IQGAP1 POTEE TENM3 NETO1 NGEF SYN1 MAST1 POTEI ATP2B3 HTT | 1.95e-05 | 891 | 162 | 20 | GO:0030424 |
| GeneOntologyCellularComponent | histone deacetylase complex | 5.23e-04 | 85 | 162 | 5 | GO:0000118 | |
| GeneOntologyCellularComponent | intracellular protein-containing complex | KLHL24 CNOT11 POP4 POTEF ACTBL2 ACTB ACTG1 POTEKP TRRAP POTEE FBXW8 KANSL1 EPC1 TRAPPC10 UBR3 PRKDC POTEI RIC1 | 5.54e-04 | 972 | 162 | 18 | GO:0140535 |
| GeneOntologyCellularComponent | dense body | 1.22e-03 | 7 | 162 | 2 | GO:0097433 | |
| GeneOntologyCellularComponent | transferase complex | KLHL24 RNMT NEK10 POTEF ACTBL2 ACTB ACTG1 POTEKP TRRAP CCNE1 POTEE FBXW8 KANSL1 EPC1 UBR3 PRKDC POTEI | 1.33e-03 | 963 | 162 | 17 | GO:1990234 |
| Domain | Actin_CS | 3.18e-11 | 16 | 160 | 7 | IPR004001 | |
| Domain | ACTINS_2 | 5.37e-11 | 17 | 160 | 7 | PS00432 | |
| Domain | Actin/actin-like_CS | 8.73e-11 | 18 | 160 | 7 | IPR020902 | |
| Domain | ACTINS_ACT_LIKE | 1.37e-10 | 19 | 160 | 7 | PS01132 | |
| Domain | Actin | 6.57e-09 | 31 | 160 | 7 | IPR004000 | |
| Domain | Actin | 6.57e-09 | 31 | 160 | 7 | PF00022 | |
| Domain | ACTIN | 6.57e-09 | 31 | 160 | 7 | SM00268 | |
| Domain | ACTINS_1 | 3.54e-07 | 8 | 160 | 4 | PS00406 | |
| Domain | LRRC37AB_C | 2.45e-06 | 4 | 160 | 3 | IPR029423 | |
| Domain | LRRC37AB_C | 2.45e-06 | 4 | 160 | 3 | PF14914 | |
| Domain | LRRC37_N | 2.45e-06 | 4 | 160 | 3 | IPR032754 | |
| Domain | LRRC37 | 2.45e-06 | 4 | 160 | 3 | PF15779 | |
| Domain | LRRC37A/B-like | 2.45e-06 | 4 | 160 | 3 | IPR015753 | |
| Pathway | REACTOME_CHONDROITIN_SULFATE_BIOSYNTHESIS | 1.48e-05 | 19 | 115 | 4 | MM14800 | |
| Pathway | REACTOME_CHONDROITIN_SULFATE_BIOSYNTHESIS | 1.84e-05 | 20 | 115 | 4 | M658 | |
| Pathway | REACTOME_RHOF_GTPASE_CYCLE | 1.96e-05 | 41 | 115 | 5 | MM15630 | |
| Pathway | REACTOME_RHOF_GTPASE_CYCLE | 2.21e-05 | 42 | 115 | 5 | M41821 | |
| Pathway | REACTOME_RHOA_GTPASE_CYCLE | 1.61e-04 | 142 | 115 | 7 | MM15576 | |
| Pubmed | Identification of a novel actin isoform in hepatocellular carcinoma. | 1.16e-15 | 15 | 162 | 8 | 16824795 | |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | SIN3B POTEF ACTBL2 KTN1 ACTB ACTG1 ACTG2 POTEKP CORO1B POTEE GTF2I POTEI | 6.27e-09 | 271 | 162 | 12 | 32433965 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | FLNB EOGT ACP3 TMC6 CHST11 WNT4 ARHGAP39 ADGRV1 TRRAP NPLOC4 DNAH14 KLHL29 PARP10 NCOR2 GTF2I NETO1 TBCK NGEF MAST1 PLA2G6 CATSPERG RIC1 NLK MAN1B1 HTT | 2.83e-08 | 1489 | 162 | 25 | 28611215 |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | FLNB RNMT COPB1 ACTG1 MCM2 CORO1B TRRAP IQGAP1 UBA1 PRKDC SEC23A HTT | 8.64e-08 | 344 | 162 | 12 | 30333137 |
| Pubmed | Biochemical Reduction of the Topology of the Diverse WDR76 Protein Interactome. | 8.96e-08 | 219 | 162 | 10 | 31353912 | |
| Pubmed | Comparative genomics and diversifying selection of the clustered vertebrate protocadherin genes. | 9.92e-08 | 3 | 162 | 3 | 15744052 | |
| Pubmed | FLNB AMPD2 POP4 VWF ACLY ACTBL2 KTN1 ACTB MSH3 IQGAP1 UBA1 PRKDC | 1.41e-07 | 360 | 162 | 12 | 33111431 | |
| Pubmed | USP45 and Spindly are part of the same complex implicated in cell migration. | 1.73e-07 | 235 | 162 | 10 | 30258100 | |
| Pubmed | Generation and annotation of the DNA sequences of human chromosomes 2 and 4. | CNOT11 MOGAT1 POTEF ACTG2 YTHDC1 SLC9A2 TENM3 TBCK NGEF UBR3 POTEI D2HGDH HTT | 1.77e-07 | 442 | 162 | 13 | 15815621 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | PLOD3 TMC6 CORO1B WRAP53 TRRAP PRAG1 RYR1 CCNE1 UNC119 NCOR2 FAT1 KANSL1 ZBED4 TMEM132A PLA2G6 PRKDC D2HGDH RIC1 PKN3 HTT | 2.44e-07 | 1105 | 162 | 20 | 35748872 |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | FLNB AMPD2 EOGT PLOD3 EMC1 HDAC6 COPB1 PDGFRA ACLY PIGS BCKDK ACTB MCM2 SQOR IQGAP1 PARP10 NCOR2 CUTA FAT1 TMEM70 CATSPERG SEC23A MAN1B1 | 2.98e-07 | 1451 | 162 | 23 | 30550785 |
| Pubmed | 3.95e-07 | 4 | 162 | 3 | 16179592 | ||
| Pubmed | 3.95e-07 | 4 | 162 | 3 | 22419166 | ||
| Pubmed | 5.98e-07 | 35 | 162 | 5 | 20946988 | ||
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | FLNB POP4 RNMT PDGFRA ACLY ACTB ACTG1 MCM2 CORO1B YTHDC1 IQGAP1 RIOX2 NCOR2 UBA1 GTF2I TRMT2A PRKDC KNL1 | 9.40e-07 | 989 | 162 | 18 | 36424410 |
| Pubmed | PLOD3 PDGFRA POTEF ACTBL2 ACTB ACTG1 ACTG2 NLRP1 POTEKP POTEE ADAMTS20 PLA2G6 PRKDC | 9.48e-07 | 513 | 162 | 13 | 25798074 | |
| Pubmed | CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer. | 1.11e-06 | 288 | 162 | 10 | 31501420 | |
| Pubmed | FLNB HDAC6 COPB1 ACLY KTN1 MTMR1 CORO1B ARHGAP39 NPLOC4 IQGAP1 ARHGAP1 UBA1 PRKDC ASCC3 ADGRL2 | 1.27e-06 | 708 | 162 | 15 | 39231216 | |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | FLNB PLOD3 VWF ACLY ACTBL2 ACP3 ADGRV1 ACY1 RYR1 IQGAP1 ARHGAP1 TGFBR3 CUTA VPS13D FAT1 UBA1 ARSF TREH | 1.38e-06 | 1016 | 162 | 18 | 19056867 |
| Pubmed | Expanding the Interactome of TES by Exploiting TES Modules with Different Subcellular Localizations. | 1.74e-06 | 235 | 162 | 9 | 28378594 | |
| Pubmed | Actin associates with the nucleocapsid domain of the human immunodeficiency virus Gag polyprotein. | 1.96e-06 | 6 | 162 | 3 | 9971772 | |
| Pubmed | Interaction of the human immunodeficiency virus type 1 nucleocapsid with actin. | 1.96e-06 | 6 | 162 | 3 | 10074138 | |
| Pubmed | Virus assembly and plasma membrane domains: which came first? | 1.96e-06 | 6 | 162 | 3 | 22989508 | |
| Pubmed | HIV-1 protease cleaves actin during acute infection of human T-lymphocytes. | 1.96e-06 | 6 | 162 | 3 | 1540415 | |
| Pubmed | HIV type 1 Gag and nucleocapsid proteins: cytoskeletal localization and effects on cell motility. | 1.96e-06 | 6 | 162 | 3 | 11709093 | |
| Pubmed | 1.96e-06 | 6 | 162 | 3 | 10049817 | ||
| Pubmed | 1.96e-06 | 6 | 162 | 3 | 12009869 | ||
| Pubmed | HIV-1 Tat protein variants: critical role for the cysteine region in synaptodendritic injury. | 1.96e-06 | 6 | 162 | 3 | 23811015 | |
| Pubmed | Retroviral assembly and budding occur through an actin-driven mechanism. | 1.96e-06 | 6 | 162 | 3 | 19883584 | |
| Pubmed | Dynamic imaging of cell-free and cell-associated viral capture in mature dendritic cells. | 1.96e-06 | 6 | 162 | 3 | 21917091 | |
| Pubmed | HIV-1 Gag protein associates with F-actin present in microfilaments. | 1.96e-06 | 6 | 162 | 3 | 8661406 | |
| Pubmed | 1.96e-06 | 6 | 162 | 3 | 23017337 | ||
| Pubmed | Synaptodendritic recovery following HIV Tat exposure: neurorestoration by phytoestrogens. | 1.96e-06 | 6 | 162 | 3 | 23875777 | |
| Pubmed | 1.96e-06 | 6 | 162 | 3 | 9841925 | ||
| Pubmed | ATP7B COPB1 PDGFRA ACLY PIGS KTN1 KATNB1 ACTB ACTG1 CHST11 MSH3 ALG2 NCOR2 GTF2I PRF1 CHST12 PRKDC ASCC3 MAN1B1 | 2.41e-06 | 1168 | 162 | 19 | 19946888 | |
| Pubmed | 3.00e-06 | 48 | 162 | 5 | 24302573 | ||
| Pubmed | 3.42e-06 | 7 | 162 | 3 | 22535526 | ||
| Pubmed | 3.42e-06 | 7 | 162 | 3 | 16059920 | ||
| Pubmed | Selective targeting of ITK blocks multiple steps of HIV replication. | 3.42e-06 | 7 | 162 | 3 | 18443296 | |
| Pubmed | The trinity of the cortical actin in the initiation of HIV-1 infection. | 3.42e-06 | 7 | 162 | 3 | 22640593 | |
| Pubmed | HIV-1 replication from after cell entry to the nuclear periphery. | 3.42e-06 | 7 | 162 | 3 | 17504171 | |
| Pubmed | 3.42e-06 | 7 | 162 | 3 | 22465675 | ||
| Pubmed | FLNB VWF COPB1 ACLY ACTBL2 KTN1 ACTB ACTG1 MTMR1 CORO1B ARHGAP39 ALG2 IQGAP1 UBA1 VCAN NGEF TRAPPC10 SYN1 MAST1 ATP2B3 SEC23A | 3.44e-06 | 1431 | 162 | 21 | 37142655 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | HDAC6 ACLY MCM2 ARHGAP39 WRAP53 YTHDC1 TRRAP IQGAP1 PASK NCOR2 UBA1 GTF2I KANSL1 TRAPPC10 PRKDC | 3.76e-06 | 774 | 162 | 15 | 15302935 |
| Pubmed | 4.16e-06 | 334 | 162 | 10 | 30425250 | ||
| Pubmed | ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells. | 5.07e-06 | 268 | 162 | 9 | 33024031 | |
| Pubmed | 5.18e-06 | 202 | 162 | 8 | 24639526 | ||
| Pubmed | 5.46e-06 | 8 | 162 | 3 | 18079434 | ||
| Pubmed | 5.46e-06 | 8 | 162 | 3 | 14694110 | ||
| Pubmed | 5.46e-06 | 8 | 162 | 3 | 20147394 | ||
| Pubmed | 5.46e-06 | 8 | 162 | 3 | 23260110 | ||
| Pubmed | 6.10e-06 | 96 | 162 | 6 | 23580065 | ||
| Pubmed | SIN3B CNOT11 POP4 PLOD3 EMC1 ACTBL2 KTN1 BCKDK ACTB ARHGAP39 WRAP53 PDCD7 YTHDC1 TRRAP SQOR IQGAP1 RIOX2 POTEE ASCC3 THAP12 MAN1B1 | 6.86e-06 | 1497 | 162 | 21 | 31527615 | |
| Pubmed | POP4 COPB1 ACLY POTEF MRPL37 ACTBL2 ACTB MRPL13 ACTG1 ACTG2 MCM2 POTEKP POTEE UBA1 GTF2I PRKDC POTEI POLQ | 7.91e-06 | 1153 | 162 | 18 | 29845934 | |
| Pubmed | Functional interaction between the cytoplasmic leucine-zipper domain of HIV-1 gp41 and p115-RhoGEF. | 8.16e-06 | 9 | 162 | 3 | 10556093 | |
| Pubmed | 8.16e-06 | 9 | 162 | 3 | 16364570 | ||
| Pubmed | Cytoskeletal proteins inside human immunodeficiency virus type 1 virions. | 8.16e-06 | 9 | 162 | 3 | 8892894 | |
| Pubmed | 8.16e-06 | 9 | 162 | 3 | 18775311 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | FLNB AMPD2 CNOT11 PLOD3 EMC1 HDAC6 ACLY ACTBL2 KTN1 ACTB ACTG1 MCM2 PDCD4 NPLOC4 IQGAP1 UBA1 GTF2I PRKDC SEC23A MAN1B1 | 1.04e-05 | 1415 | 162 | 20 | 28515276 |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | FLNB ACLY POTEF ACP3 ACTB ACTG1 ACTG2 POTEKP CORO1B ACY1 IQGAP1 ARHGAP1 POTEE CUTA UBA1 TMEM132A POTEI | 1.15e-05 | 1070 | 162 | 17 | 23533145 |
| Pubmed | 1.16e-05 | 10 | 162 | 3 | 1907279 | ||
| Pubmed | 1.16e-05 | 10 | 162 | 3 | 23064749 | ||
| Pubmed | Non-viral cellular substrates for human immunodeficiency virus type 1 protease. | 1.16e-05 | 10 | 162 | 3 | 1991513 | |
| Pubmed | 1.16e-05 | 10 | 162 | 3 | 23575248 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | SIN3B HDAC6 ACLY KTN1 MTMR1 MSH3 YTHDC1 TRRAP NCOR2 FBXW8 TRMT2A KANSL1 EPC1 ADGRL2 ATP2B3 | 1.26e-05 | 857 | 162 | 15 | 25609649 |
| Pubmed | 1.36e-05 | 65 | 162 | 5 | 22496869 | ||
| Pubmed | 1.59e-05 | 11 | 162 | 3 | 30962377 | ||
| Pubmed | N-terminal Slit2 inhibits HIV-1 replication by regulating the actin cytoskeleton. | 1.59e-05 | 11 | 162 | 3 | 23294842 | |
| Pubmed | Quantitative proteomic analysis of lentiviral vectors using 2-DE. | 1.59e-05 | 11 | 162 | 3 | 19639585 | |
| Pubmed | RNMT HDAC6 ACLY MRPL37 ACTB MRPL13 MCM2 POTEKP TRRAP NPLOC4 IQGAP1 RIOX2 PASK UBA1 GTF2I TBCK PRKDC ASCC3 SEC23A | 1.60e-05 | 1335 | 162 | 19 | 29229926 | |
| Pubmed | BMPR2 is required for postimplantation uterine function and pregnancy maintenance. | 1.89e-05 | 34 | 162 | 4 | 23676498 | |
| Pubmed | 2.12e-05 | 12 | 162 | 3 | 23071112 | ||
| Pubmed | 2.12e-05 | 12 | 162 | 3 | 34169071 | ||
| Pubmed | Beta- and gamma-cytoplasmic actins are required for meiosis in mouse oocytes. | 2.16e-05 | 2 | 162 | 2 | 21778137 | |
| Pubmed | De novo mutations in the actin genes ACTB and ACTG1 cause Baraitser-Winter syndrome. | 2.16e-05 | 2 | 162 | 2 | 22366783 | |
| Pubmed | Prenatal presentation and diagnosis of Baraitser-Winter syndrome using exome sequencing. | 2.16e-05 | 2 | 162 | 2 | 32588558 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 27625340 | ||
| Pubmed | A primate-specific POTE-actin fusion protein plays a role in apoptosis. | 2.16e-05 | 2 | 162 | 2 | 19669888 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 3221869 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 22986533 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 10207172 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 2747639 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 10544197 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 21502360 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 33404279 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 6686106 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 213279 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 33334799 | ||
| Pubmed | β-Actin specifically controls cell growth, migration, and the G-actin pool. | 2.16e-05 | 2 | 162 | 2 | 21900491 | |
| Pubmed | Beta and gamma-cytoplasmic actins display distinct distribution and functional diversity. | 2.16e-05 | 2 | 162 | 2 | 19638415 | |
| Pubmed | Botulinum C2 toxin ADP-ribosylates cytoplasmic beta/gamma-actin in arginine 177. | 2.16e-05 | 2 | 162 | 2 | 3335520 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 9288906 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 1577857 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 38267530 | ||
| Pubmed | IQGAP1 promotes chronic pain by regulating the trafficking and sensitization of TRPA1 channels. | 2.16e-05 | 2 | 162 | 2 | 36477832 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 26583190 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 32326615 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 36044851 | ||
| Pubmed | Severe forms of Baraitser-Winter syndrome are caused by ACTB mutations rather than ACTG1 mutations. | 2.16e-05 | 2 | 162 | 2 | 23756437 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 34202629 | ||
| Interaction | ACTG2 interactions | 4.76e-09 | 49 | 161 | 8 | int:ACTG2 | |
| Interaction | WASH8P interactions | 1.24e-06 | 11 | 161 | 4 | int:WASH8P | |
| Interaction | COBL interactions | 2.99e-06 | 78 | 161 | 7 | int:COBL | |
| Interaction | POTEJ interactions | 3.56e-06 | 52 | 161 | 6 | int:POTEJ | |
| Interaction | SCIN interactions | 6.80e-06 | 58 | 161 | 6 | int:SCIN | |
| Interaction | RASA1 interactions | 8.08e-06 | 167 | 161 | 9 | int:RASA1 | |
| Interaction | ITGB3 interactions | 9.33e-06 | 170 | 161 | 9 | int:ITGB3 | |
| Interaction | ISG15 interactions | FLNB PLOD3 EMC1 HDAC6 ACLY ACTBL2 ACTB ACTG1 YTHDC1 SQOR NPLOC4 IQGAP1 UBA1 PRKDC ASCC3 | 1.05e-05 | 494 | 161 | 15 | int:ISG15 |
| Interaction | POTEE interactions | 1.24e-05 | 134 | 161 | 8 | int:POTEE | |
| Interaction | CAP2 interactions | 1.45e-05 | 66 | 161 | 6 | int:CAP2 | |
| Interaction | POTEF interactions | 1.54e-05 | 228 | 161 | 10 | int:POTEF | |
| Interaction | PDCL3 interactions | 1.57e-05 | 100 | 161 | 7 | int:PDCL3 | |
| Interaction | ERRFI1 interactions | 2.43e-05 | 107 | 161 | 7 | int:ERRFI1 | |
| Interaction | C2CD4B interactions | 2.58e-05 | 44 | 161 | 5 | int:C2CD4B | |
| Interaction | ACTBL2 interactions | HDAC6 POTEF ACTBL2 ACTB ACTG1 ACTG2 MCM2 POTEE TMEM70 POTEI HTT | 2.70e-05 | 296 | 161 | 11 | int:ACTBL2 |
| Interaction | DNAJA2 interactions | POP4 EMC1 HDAC6 COPB1 PIGS TTLL5 MCM2 WRAP53 TRRAP SQOR TRMT2A PRKDC ASCC3 EPAS1 HTT | 3.08e-05 | 542 | 161 | 15 | int:DNAJA2 |
| Interaction | TOP3B interactions | CNOT11 PLOD3 KTN1 TMC6 ACTG1 MSH3 CORO1B WRAP53 TRRAP PRAG1 RYR1 IQGAP1 CCNE1 UNC119 NCOR2 FAT1 GTF2I KANSL1 ZBED4 TMEM132A PLA2G6 PRKDC D2HGDH SEC23A RIC1 PKN3 HTT | 3.97e-05 | 1470 | 161 | 27 | int:TOP3B |
| Interaction | PFN2 interactions | 4.26e-05 | 159 | 161 | 8 | int:PFN2 | |
| Interaction | CAP1 interactions | 4.44e-05 | 207 | 161 | 9 | int:CAP1 | |
| Interaction | WDR76 interactions | FLNB PLOD3 COPB1 ACTBL2 ACTB ACTG1 MSH3 TRRAP UBA1 GTF2I VCAN PRKDC | 6.13e-05 | 383 | 161 | 12 | int:WDR76 |
| Interaction | PHACTR2 interactions | 7.98e-05 | 29 | 161 | 4 | int:PHACTR2 | |
| Interaction | CDKN2A interactions | PDGFRA ACLY ACTBL2 ACTB ACTG1 MCM2 TRRAP IQGAP1 AZIN1 CCNE1 NCOR2 | 8.25e-05 | 335 | 161 | 11 | int:CDKN2A |
| Interaction | RAC2 interactions | EMC1 PIGS KTN1 ACTB MTMR1 ARHGAP39 TRRAP IQGAP1 ARHGAP1 POTEE VPS13D FAT1 UBA1 TENM3 ADGRL2 HTT | 1.03e-04 | 674 | 161 | 16 | int:RAC2 |
| Interaction | GC interactions | 1.37e-04 | 62 | 161 | 5 | int:GC | |
| Interaction | ERBB3 interactions | RNMT HDAC6 PDGFRA POTEF ACTBL2 ACTB ACTG1 MTMR1 ACTG2 POTEKP POTEE | 1.38e-04 | 355 | 161 | 11 | int:ERBB3 |
| Cytoband | 2q21.1 | 5.46e-05 | 58 | 162 | 4 | 2q21.1 | |
| GeneFamily | Ankyrin repeat domain containing|POTE ankyrin domain containing | 6.31e-07 | 13 | 101 | 4 | 685 | |
| GeneFamily | Actins | 3.34e-06 | 6 | 101 | 3 | 929 | |
| GeneFamily | Cadherin related | 1.09e-04 | 17 | 101 | 3 | 24 | |
| GeneFamily | Cation channels sperm associated | 6.37e-04 | 7 | 101 | 2 | 186 | |
| GeneFamily | Transmembrane channel likes | 8.46e-04 | 8 | 101 | 2 | 1135 | |
| GeneFamily | Sulfotransferases, membrane bound | 1.15e-03 | 37 | 101 | 3 | 763 | |
| GeneFamily | Rho GTPase activating proteins|BCH domain containing | 2.74e-03 | 50 | 101 | 3 | 721 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-SPN_Neuron_STR|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-07 | 165 | 162 | 8 | 1b7dfa173e83aa8c46a3153a3261866c065c3b73 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-medium_spiny_neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-07 | 165 | 162 | 8 | b4f7d33af7d053ec07b01bd67d861600a9c4822e | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-GLP2R--|Neuronal / cells hierarchy compared to all cells using T-Statistic | 7.29e-07 | 200 | 162 | 8 | dc8702e3cb4ac8c1a9849fc8abf8777f12d55b0b | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-GLP2R---L2-4|Neuronal / cells hierarchy compared to all cells using T-Statistic | 7.29e-07 | 200 | 162 | 8 | d92d51021ab6d78e9c8f89f7c150181004dcbcbd | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-GLP2R-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 7.29e-07 | 200 | 162 | 8 | cbbb9044283ff9ab63bbfc24d7a9f006b1372705 | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-GLP2R|Neuronal / cells hierarchy compared to all cells using T-Statistic | 7.29e-07 | 200 | 162 | 8 | a3e36bbeed19431d07bc205f14f4e0f12bd8f730 | |
| ToppCell | CV-Severe-7|Severe / Virus stimulation, Condition and Cluster | 3.95e-06 | 177 | 162 | 7 | 82fdd6185b368f54f03de389427cbe3071d21a99 | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.58e-06 | 181 | 162 | 7 | 4ea02344e1996f264dd5e14f3b19c8782ce41699 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.47e-06 | 186 | 162 | 7 | 56c139e679d640ea901ead657a8e8887e0fca098 | |
| ToppCell | facs-Spleen-nan-3m-Lymphocytic-CD79a_B_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.67e-06 | 187 | 162 | 7 | b51af2824e65734f333b1325117f4a2e88b17c23 | |
| ToppCell | facs-Spleen-nan-3m-Lymphocytic-B_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.67e-06 | 187 | 162 | 7 | 3ca3954f45f167e98a230f2847f0582d74fcd32e | |
| ToppCell | RA-09._Endothelium_I|World / Chamber and Cluster_Paper | 6.51e-06 | 191 | 162 | 7 | c8a0c2af119bc34a8f694a7d30642f28002c84b9 | |
| ToppCell | ASK440-Endothelial-Endothelium|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 7.46e-06 | 195 | 162 | 7 | 304f0dc91bb57e98b0ca31d6bfb3ff9364e4da56 | |
| ToppCell | Mild-CD8+_T_activated|World / Disease group and Cell class | 7.71e-06 | 196 | 162 | 7 | 79632190e44fcef9d7c11d9b9e37f2ebf0e6e255 | |
| ToppCell | ILEUM-non-inflamed-(8)_Fibroblast-(8)_Smooth_muscle_cells|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 7.97e-06 | 197 | 162 | 7 | 4e0c3ea4f4a04a41532806edf3bccf7845c86fa5 | |
| ToppCell | Endothelial-A|World / lung cells shred on cell class, cell subclass, sample id | 8.24e-06 | 198 | 162 | 7 | dd096d4b9f428615f927f7df7cbf5cede0e0e605 | |
| ToppCell | 367C-Endothelial_cells|367C / Donor, Lineage, Cell class and subclass (all cells) | 8.51e-06 | 199 | 162 | 7 | 636ff80938907f137e955388797072ab45289062 | |
| ToppCell | kidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.51e-06 | 199 | 162 | 7 | 174f6013af6eafa577f84205a62927f2b367fda3 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 8.79e-06 | 200 | 162 | 7 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 8.79e-06 | 200 | 162 | 7 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Dendritic-conventional_dendritic_cell-DC_c3-LAMP3|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.20e-05 | 139 | 162 | 6 | bb2b020dda32ddc60ec9952de5b01acee60b5b59 | |
| ToppCell | LPS-IL1RA+antiTNF-Unknown-Endothelial-Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.15e-05 | 154 | 162 | 6 | 16fdafb5c64d2db321554f87129a962d113f1668 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.06e-05 | 164 | 162 | 6 | f88871d3b9307112eb7ced4c629f5704326ecae8 | |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_prolif|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.17e-05 | 165 | 162 | 6 | ba68090d79e2243af2bdee0c27a32e65f540f8ac | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Myeloid-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.28e-05 | 166 | 162 | 6 | 35db3022c33d6f8bb6587d9eec89a7cccb70271a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.39e-05 | 167 | 162 | 6 | 108ae6221c6edc63c0ec42c42471b3a15a594043 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_artery-D122|Adult / Lineage, Cell type, age group and donor | 3.50e-05 | 168 | 162 | 6 | 8c3e1e45b422813bcdfa4273b1167db649a312f5 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.26e-05 | 174 | 162 | 6 | 1d157f7a919c8246e83d8060d2a0017c6c781ef3 | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.47e-05 | 182 | 162 | 6 | a20017b6a4f9a6a29e090e4dbd7c02ed1495bd50 | |
| ToppCell | Control-Endothelial_cells-Pulmonary_venous_endothelial_cells|Control / group, cell type (main and fine annotations) | 5.64e-05 | 183 | 162 | 6 | 46be9f96755c7b65aeac061d95d15abeb6466034 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.81e-05 | 184 | 162 | 6 | 16ed515fb673a9d6973133afcda0a3fba4a8d9dc | |
| ToppCell | COVID-19-Endothelial_cells-Systemic_venous_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 5.99e-05 | 185 | 162 | 6 | f5e14181f45c37d13ee9e017a4c8bc248c353676 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.99e-05 | 185 | 162 | 6 | a2cae8c657e4f4d121476798e424876f7e247973 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.99e-05 | 185 | 162 | 6 | d50406a9a5b8d75110ba5985741aa2293950c543 | |
| ToppCell | Endothelial-A-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 5.99e-05 | 185 | 162 | 6 | dee0b7ba2f338f0979d2306aedf52ac35a36b60c | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.99e-05 | 185 | 162 | 6 | a7ae76058b2082020cadec49d63b9f4e24d21734 | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.17e-05 | 186 | 162 | 6 | f07e0c0d9c80ac9d8d679950e7d0c812becb85a3 | |
| ToppCell | LV-10._Endothelium_II|World / Chamber and Cluster_Paper | 6.36e-05 | 187 | 162 | 6 | 7876dcb4800c2e54874df3d933efb79307a64a97 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.36e-05 | 187 | 162 | 6 | 1b2fdbfb1ce3f19795dfc4b1da5a94f4b057ec41 | |
| ToppCell | facs-Lung-3m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.36e-05 | 187 | 162 | 6 | 7170694a1b86fe8d84d96c880ffe57af09bdc026 | |
| ToppCell | Frontal_cortex-Endothelial|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 6.55e-05 | 188 | 162 | 6 | a43392dbd10fc7dbfb31be39b8af8a7ea121c894 | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 6.55e-05 | 188 | 162 | 6 | 0758b474457efa36488e0195f7357100f4b6a090 | |
| ToppCell | COVID-19-lung-Vein_EC|lung / Disease (COVID-19 only), tissue and cell type | 6.55e-05 | 188 | 162 | 6 | d582b76fc2faac526c9bf97503041129e1a6a211 | |
| ToppCell | droplet-Lung-3m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-proliferating_NK|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.55e-05 | 188 | 162 | 6 | 0ec2a1b0505501ba18f10a5fce68c306a6292419 | |
| ToppCell | Endothelial-A-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 6.55e-05 | 188 | 162 | 6 | 0824d567356d360fd8e78e840c30529c139f98a1 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.74e-05 | 189 | 162 | 6 | 160963355256f7c0f2138da80c90de478f5a9fe8 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.74e-05 | 189 | 162 | 6 | 979b7fa947538aa7ca4a219263da2575869a2caa | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Endothelial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.94e-05 | 190 | 162 | 6 | 1ff2295c9fc94ea21fff286706b739d0deb032d0 | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Endothelial-endothelial_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.94e-05 | 190 | 162 | 6 | 61f2f9fb4b8f47a2a669f6b052214d2ce0c194cd | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Endothelial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.94e-05 | 190 | 162 | 6 | d415c8f3d69a8142e95307aeabc6d0e812cd5165 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.94e-05 | 190 | 162 | 6 | 3f0c7d130f66faea778fe567604edf1b4cdf85b3 | |
| ToppCell | facs-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l10|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.94e-05 | 190 | 162 | 6 | 2655df8c0883dd811fa7617301f9c4b0a4dd55ec | |
| ToppCell | Endothelial-A-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 7.15e-05 | 191 | 162 | 6 | f702dfe88a9b04091dae87df61b2b4f43525f86a | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 7.15e-05 | 191 | 162 | 6 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|World / Lineage, Cell type, age group and donor | 7.35e-05 | 192 | 162 | 6 | 1e156bab5ecf64627890d2de9b27603d9a01f28d | |
| ToppCell | RA-09._Endothelium_I|RA / Chamber and Cluster_Paper | 7.35e-05 | 192 | 162 | 6 | 8a1b1c3e83a68ad74f8f4eb00455c9e41aa57cfc | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.35e-05 | 192 | 162 | 6 | bd3fa6c8fcb618db64d11f25cabaf08608957c35 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.35e-05 | 192 | 162 | 6 | c09dcc73ff9c3855a0f3d7bfa0d5c99c09a117f2 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.57e-05 | 193 | 162 | 6 | bbdfda6665941cfa1965418bb91ef9ff43b1326f | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-VEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.57e-05 | 193 | 162 | 6 | 9ba688b35a9ead5d04691b3f3f15484f02dbbd0d | |
| ToppCell | IPF-Endothelial-VE_Venous|IPF / Disease state, Lineage and Cell class | 7.57e-05 | 193 | 162 | 6 | 29a655fa80feaabe846c90a28363b037e22d24ae | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.57e-05 | 193 | 162 | 6 | 287e756d5fd3bd2931c168da24beaa0d02a350ae | |
| ToppCell | 390C-Endothelial_cells-Endothelial-B_(Artery)|390C / Donor, Lineage, Cell class and subclass (all cells) | 7.79e-05 | 194 | 162 | 6 | f8a59bd4609d147d8a706bf606e9e8173c9992a3 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-B_(Artery)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 7.79e-05 | 194 | 162 | 6 | 04b1acc2e879feafb43f75435281c5acd8d23be2 | |
| ToppCell | LV-10._Endothelium_II|LV / Chamber and Cluster_Paper | 7.79e-05 | 194 | 162 | 6 | b6cc849fa08599bff9839ef382d190cc964e273e | |
| ToppCell | (6)_Endothelial-B_(Artery)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 7.79e-05 | 194 | 162 | 6 | 0cf4e67d4024652794b5bfdd4a71a7d98900b4c8 | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.01e-05 | 195 | 162 | 6 | d77423d0ec64b397c6d1eec181c5fc0acaa92d63 | |
| ToppCell | droplet-Lung-18m-Endothelial-venous_endothelial-vein_endothelial_cell-vein_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.01e-05 | 195 | 162 | 6 | 0c15be3e7c238e329505dcbbe197a977d1019d45 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-osteoblast_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 8.01e-05 | 195 | 162 | 6 | ec12cfb2fce44cc2de4e198ef5af075e626f0329 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.01e-05 | 195 | 162 | 6 | 4658fb197657d7692ee344ae76b11b0210c418ba | |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 8.01e-05 | 195 | 162 | 6 | a78b605b49acd8c9d68716266ca269dafcd910b9 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.01e-05 | 195 | 162 | 6 | 98ca9f3aa36211dde1e6f7f3817b9418c95e583e | |
| ToppCell | droplet-Lung-18m-Endothelial-venous_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.01e-05 | 195 | 162 | 6 | 45ac0fdbeb0982d798c613a6d15715d725608aa9 | |
| ToppCell | droplet-Lung-18m-Endothelial-venous_endothelial-vein_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.01e-05 | 195 | 162 | 6 | 5b1f04a745467876b09113ee17ababd3fcf9fb01 | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.01e-05 | 195 | 162 | 6 | f5bf4797972185afa76638293166abd536e5472f | |
| ToppCell | ASK428-Endothelial-Endothelium|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 8.24e-05 | 196 | 162 | 6 | b1a81eddb91fb462360692b7b0a3ba4a947eac40 | |
| ToppCell | facs-Bladder-nan-3m|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.24e-05 | 196 | 162 | 6 | 44f5b1b474399c9316729155f2ea95a82ca66e30 | |
| ToppCell | Fibroblasts-DKK3+_Fibroblasts|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 8.24e-05 | 196 | 162 | 6 | 24d64b67aa9b0e8215ad06f9101c1314b3483620 | |
| ToppCell | facs-Bladder-nan-3m-Epithelial|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.24e-05 | 196 | 162 | 6 | c0e90d964baa2eb4fbd18a52379ccec5d3bf59a8 | |
| ToppCell | ASK440-Endothelial-Endothelium|Endothelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 8.40e-05 | 122 | 162 | 5 | 2f76ec3b527e9528fbb006599a96e8bbdf9e0e62 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma-osteoblast_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.47e-05 | 197 | 162 | 6 | 2f72fd9a5b6d62c24a95ed2246194ea7458c0f12 | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 8.47e-05 | 197 | 162 | 6 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated-Deuterosomal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.47e-05 | 197 | 162 | 6 | 6e4a411ef823ce9e16f420e185e21fa19d13af34 | |
| ToppCell | droplet-Bladder-nan-24m-Endothelial-endothelial_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.47e-05 | 197 | 162 | 6 | 488e85991c5e668afb7672942726d9295b8fc7d8 | |
| ToppCell | CV-Severe-1|CV / Virus stimulation, Condition and Cluster | 8.71e-05 | 198 | 162 | 6 | fc0e885e370ffb780eada62bb2b52065c2f8b26b | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.71e-05 | 198 | 162 | 6 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | distal-Endothelial-Artery-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.71e-05 | 198 | 162 | 6 | f284f59f4ebe55ee132eddfaa2f5d9ecb059654f | |
| ToppCell | CV|World / Virus stimulation, Condition and Cluster | 8.71e-05 | 198 | 162 | 6 | 6a28193af35abec5c029129930c2ca6febaafde2 | |
| ToppCell | CD8+_Memory_T_cell-CV|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 8.71e-05 | 198 | 162 | 6 | 3d1749f5106f0912f4a74615863853949f52c73d | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.71e-05 | 198 | 162 | 6 | 399760b6b6fef8639ded53b14f251b9fce600e81 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.71e-05 | 198 | 162 | 6 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Bronchial_vessel|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.96e-05 | 199 | 162 | 6 | 53b6a661d381b1ed3ea96e61e8bd1750de7d9fda | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_pulmonary_venous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.96e-05 | 199 | 162 | 6 | 3a4deea6e11a0555d27497b7c9983350797aac69 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.96e-05 | 199 | 162 | 6 | d65ee89d5c7e8ed693d58e6a6de09565840e11c5 | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.96e-05 | 199 | 162 | 6 | 7ed541309808f15d65a9c4b26be2050e077539e6 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4/8-lo-Cycling_T|lymph-node_spleen / Manually curated celltypes from each tissue | 8.96e-05 | 199 | 162 | 6 | 28fc342d2d178ce33203a78eb9eedae54fa9c916 | |
| ToppCell | Parenchyma_Control_(B.)-Endothelial-TX-Bronchial_vessel|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 8.96e-05 | 199 | 162 | 6 | 9c753043024871b1f1436fc39defac4da85e10cd | |
| ToppCell | ASK452-Endothelial|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 8.96e-05 | 199 | 162 | 6 | 0bc97a9a78aaafd1554ae6a61356ed9ea4983fa5 | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Bronchial_vessel-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.96e-05 | 199 | 162 | 6 | d017dd91f9b10038f1f83753a766e534da2dbe89 | |
| ToppCell | Parenchymal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_pulmonary_venous|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 8.96e-05 | 199 | 162 | 6 | 15db14eff63d5edeced0738542d5fb739225511b | |
| Drug | AC1OAGGW | PDGFRA ACTBL2 ACTB ACTG1 ACTG2 DGKG ARHGAP1 PLCXD3 PLCB2 PKN3 | 2.03e-06 | 203 | 162 | 10 | CID006857364 |
| Drug | (2S,3R)-Sphingosine | GPR4 ACTBL2 ACTB ACTG1 ACTG2 DGKG ACY1 TTPA RYR1 PLA2G6 PLCXD3 PLCB2 PKN3 | 4.52e-06 | 389 | 162 | 13 | CID000001104 |
| Drug | mDia | 4.60e-06 | 93 | 162 | 7 | CID000128346 | |
| Drug | Nsc687160 | 6.99e-06 | 18 | 162 | 4 | CID005459290 | |
| Drug | tolytoxin | 8.81e-06 | 19 | 162 | 4 | CID006440827 | |
| Drug | AC1L1ERT | 9.79e-06 | 69 | 162 | 6 | CID000002920 | |
| Drug | enantio-PAF-C16 | 1.03e-05 | 244 | 162 | 10 | CID000002499 | |
| Drug | NSC312786 | 1.34e-05 | 21 | 162 | 4 | CID000329495 | |
| Drug | AC1L8NVR | 1.34e-05 | 21 | 162 | 4 | CID000384633 | |
| Drug | AC1Q5THZ | VWF ACTBL2 ACTB ACTG1 ACTG2 DGKG PTGIS PARP10 PLA2G6 PLCXD3 PLCB2 ATP2B3 THAP12 PKN3 | 1.51e-05 | 502 | 162 | 14 | CID000001959 |
| Drug | peroxynitrite | ACTBL2 ACTB ACTG1 ACTG2 NLRP1 TTPA PTGIS RYR1 PARP10 NETO1 ATP2B3 NLK | 1.56e-05 | 373 | 162 | 12 | CID000104806 |
| Drug | tetramethylrhodamine isothiocyanate | 2.07e-05 | 47 | 162 | 5 | CID004123009 | |
| Drug | plakin | 2.65e-05 | 82 | 162 | 6 | CID000018752 | |
| Drug | formamide | 3.25e-05 | 85 | 162 | 6 | CID000000713 | |
| Drug | AC1L1BDQ | 3.46e-05 | 173 | 162 | 8 | CID000001394 | |
| Drug | D-myo-inositol 1,4-bisphosphate | 3.48e-05 | 86 | 162 | 6 | CID000000805 | |
| Drug | beta-tocopherol | 3.81e-05 | 27 | 162 | 4 | CID000008989 | |
| Drug | U46619 | 3.92e-05 | 285 | 162 | 10 | CID000005618 | |
| Drug | CID5288653 | 4.43e-05 | 28 | 162 | 4 | CID005288653 | |
| Drug | TCM3 | 5.03e-05 | 2 | 162 | 2 | CID000017519 | |
| Drug | C2-ceramide | 5.09e-05 | 294 | 162 | 10 | CID000002505 | |
| Drug | AGEPC | VWF ACTBL2 ACTB ACTG1 ACTG2 NETO1 PLA2G6 PLCXD3 PLCB2 PKN3 NLK | 5.11e-05 | 356 | 162 | 11 | CID000461545 |
| Drug | phorbol acetate myristate | TRPA1 PDGFRA ACTBL2 ACTB ACTG1 ACTG2 DGKG NLRP1 TTPA RYR1 MAP3K1 IQGAP1 TGFBR3 SLC9A2 SAMD9L TREH VCAN PLA2G6 PLCXD3 PLCB2 POLQ THAP12 PKN3 NLK | 5.46e-05 | 1399 | 162 | 24 | CID000004792 |
| Drug | bistheonellide A | 5.60e-05 | 11 | 162 | 3 | CID006441172 | |
| Drug | Viroisin | 5.60e-05 | 11 | 162 | 3 | CID000119538 | |
| Drug | AC1NRBPQ | 5.75e-05 | 137 | 162 | 7 | CID005288569 | |
| Drug | D-myo-inositol-1,4,5-triphosphate | TRPA1 PDGFRA ACTBL2 ACTB ACTG1 ACTG2 DGKG RYR1 PLCXD3 PLCB2 ATP2B3 PKN3 NLK HTT | 5.79e-05 | 568 | 162 | 14 | CID000000806 |
| Drug | azaspiracid | 5.86e-05 | 30 | 162 | 4 | CID006451158 | |
| Drug | manidipine | 6.10e-05 | 95 | 162 | 6 | CID000004008 | |
| Drug | phosphatidate | GPR4 MOGAT1 ACLY ACTBL2 ACTB ACTG1 ACTG2 DGKG PLA2G6 PLCXD3 PLCB2 PKN3 | 6.48e-05 | 432 | 162 | 12 | CID005460104 |
| Drug | AC1L1JYL | GPR4 PDGFRA ACTBL2 ACTB ACTG1 ACTG2 ACY1 PLA2G6 PLCXD3 PLCB2 PKN3 NLK | 6.77e-05 | 434 | 162 | 12 | CID000005262 |
| Drug | POPC | 7.10e-05 | 306 | 162 | 10 | CID000065167 | |
| Drug | 6-trans-leukotriene B4 | 7.20e-05 | 247 | 162 | 9 | CID000000169 | |
| Drug | 0317956-0000 [391210-11-0]; Down 200; 1uM; PC3; HT_HG-U133A | 7.22e-05 | 192 | 162 | 8 | 4334_DN | |
| Drug | BFDGE | 7.42e-05 | 12 | 162 | 3 | CID000091511 | |
| Drug | AC1L1HS4 | 7.60e-05 | 32 | 162 | 4 | CID000004267 | |
| Drug | Rp-cAMPS | 7.76e-05 | 194 | 162 | 8 | CID006426631 | |
| Drug | prostacyclin sodium salt | 7.90e-05 | 250 | 162 | 9 | CID000000159 | |
| Drug | nitric oxide | VWF ATP7B PDGFRA ACTBL2 ACTB ACTG1 ACTG2 NLRP1 TTPA PTGIS RYR1 PARP10 SLC9A2 NETO1 VCAN PRKDC ATP2B3 EPAS1 PKN3 NLK | 8.18e-05 | 1075 | 162 | 20 | CID000145068 |
| Drug | Bezafibrate [41859-67-0]; Down 200; 11uM; PC3; HT_HG-U133A | 8.33e-05 | 196 | 162 | 8 | 6653_DN | |
| Drug | Pirenzepine dihydrochloride [29868-97-1]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 8.33e-05 | 196 | 162 | 8 | 7226_DN | |
| Drug | Tolazoline hydrochloride [59-97-2]; Down 200; 20.4uM; MCF7; HT_HG-U133A | 8.33e-05 | 196 | 162 | 8 | 4844_DN | |
| Drug | Gly-His-Lys acetate salt; Up 200; 1uM; PC3; HT_HG-U133A | 8.33e-05 | 196 | 162 | 8 | 6570_UP | |
| Drug | dihydrosphingosine | 8.59e-05 | 146 | 162 | 7 | CID000003126 | |
| Drug | Ungerine nitrate; Down 200; 10.2uM; HL60; HT_HG-U133A | 8.64e-05 | 197 | 162 | 8 | 2514_DN | |
| Drug | oryzalin | 8.64e-05 | 63 | 162 | 5 | CID000029393 | |
| Drug | Nicardipine hydrochloride [54527-84-3]; Down 200; 7.8uM; PC3; HT_HG-U133A | 8.95e-05 | 198 | 162 | 8 | 6297_DN | |
| Drug | Pirenperone [ 75444-65-4]; Down 200; 10.2uM; HL60; HT_HG-U133A | 8.95e-05 | 198 | 162 | 8 | 2455_DN | |
| Drug | Benzonatate [104-31-4]; Up 200; 6.6uM; PC3; HT_HG-U133A | 9.26e-05 | 199 | 162 | 8 | 6334_UP | |
| Drug | N,N'-p-phenylenedimaleimide | 9.70e-05 | 34 | 162 | 4 | CID000076765 | |
| Drug | astragaloside A | 9.70e-05 | 34 | 162 | 4 | CID000122690 | |
| Drug | 1,N6-ethenoadenosine 5'-diphosphate | 9.70e-05 | 34 | 162 | 4 | CID000001312 | |
| Drug | methenamine silver | 9.93e-05 | 201 | 162 | 8 | CID000004101 | |
| Drug | 9-beta-D-arabinofuranosylguanine | POP4 RNMT COPB1 ACTBL2 ACTB MC1R ACTG1 ACTG2 WNT4 ENTPD4 MAP3K1 IQGAP1 ARHGAP1 PLCXD3 PLCB2 POLQ PKN3 | 1.11e-04 | 843 | 162 | 17 | CID000000765 |
| Drug | kabiramide C | 1.22e-04 | 14 | 162 | 3 | CID005288658 | |
| Drug | AC1OAGFB | VWF PDGFRA ACTBL2 ACTB ACTG1 ACTG2 DGKG TRRAP TXNDC11 ARHGAP1 PLCXD3 PLCB2 PKN3 | 1.33e-04 | 539 | 162 | 13 | CID006857345 |
| Drug | LG100268 | 1.33e-04 | 69 | 162 | 5 | CID000003922 | |
| Drug | caged ATP | 1.43e-04 | 70 | 162 | 5 | CID000123806 | |
| Drug | AC1LCK6O | 1.50e-04 | 3 | 162 | 2 | CID000631939 | |
| Drug | RHC 80267 | 1.52e-04 | 112 | 162 | 6 | CID000005063 | |
| Drug | triphosphoinositide | 1.54e-04 | 273 | 162 | 9 | CID009543520 | |
| Drug | HU-211 | 1.67e-04 | 114 | 162 | 6 | CID000107778 | |
| Disease | Moyamoya disease (implicated_via_orthology) | 2.01e-10 | 8 | 154 | 5 | DOID:13099 (implicated_via_orthology) | |
| Disease | autosomal dominant nonsyndromic deafness 20 (implicated_via_orthology) | 2.01e-10 | 8 | 154 | 5 | DOID:0110550 (implicated_via_orthology) | |
| Disease | Baraitser-Winter syndrome 1 (implicated_via_orthology) | 2.01e-10 | 8 | 154 | 5 | DOID:0081112 (implicated_via_orthology) | |
| Disease | thoracic aortic aneurysm (implicated_via_orthology) | 2.01e-10 | 8 | 154 | 5 | DOID:14004 (implicated_via_orthology) | |
| Disease | intestinal atresia (implicated_via_orthology) | 8.95e-10 | 10 | 154 | 5 | DOID:10486 (implicated_via_orthology) | |
| Disease | patent ductus arteriosus (implicated_via_orthology) | 8.95e-10 | 10 | 154 | 5 | DOID:13832 (implicated_via_orthology) | |
| Disease | Metastatic melanoma | 9.34e-06 | 54 | 154 | 5 | C0278883 | |
| Disease | Baraitser-Winter syndrome | 2.71e-05 | 2 | 154 | 2 | cv:C1853623 | |
| Disease | Iris Coloboma with Ptosis, Hypertelorism, and Mental Retardation | 2.71e-05 | 2 | 154 | 2 | C1855722 | |
| Disease | Fryns-Aftimos Syndrome | 2.71e-05 | 2 | 154 | 2 | C1853623 | |
| Disease | hair colour measurement, hair morphology measurement | 2.96e-05 | 12 | 154 | 3 | EFO_0007821, EFO_0007822 | |
| Disease | obsolete_red blood cell distribution width | KLHL24 ZNF280D TMC6 LRRC37A2 MCM2 NPLOC4 TXNDC11 MAP3K1 IQGAP1 CCNE1 PARP10 GTF2I KANSL1 MAST1 PLA2G6 TRIM38 ATP2B3 KNL1 | 2.44e-04 | 1347 | 154 | 18 | EFO_0005192 |
| Disease | seasonality measurement, vitamin D measurement | 2.68e-04 | 5 | 154 | 2 | EFO_0004631, EFO_0006876 | |
| Disease | Malignant neoplasm of breast | FLNB VWF ATP7B PIGS KTN1 LRRC37A2 MRPL13 DGKG ACY1 PDCD4 MAP3K1 CCNE1 SLC9A2 LRRC37A TRMT2A | 5.22e-04 | 1074 | 154 | 15 | C0006142 |
| Disease | ventral diencephalon volume measurement | 5.59e-04 | 7 | 154 | 2 | EFO_0010337 | |
| Disease | Uveoretinal Coloboma | 5.59e-04 | 7 | 154 | 2 | C4554007 | |
| Disease | putamen volume | 5.63e-04 | 31 | 154 | 3 | EFO_0006932 | |
| Disease | cortical surface area measurement | FLNB COPB1 FAT3 WNT4 ARHGAP39 ADGRV1 NPLOC4 MAP3K1 KLHL29 ARHGAP1 KANSL1 TREH VCAN RASGEF1B ADAMTS20 CD180 ADGRL2 | 6.84e-04 | 1345 | 154 | 17 | EFO_0010736 |
| Disease | ovarian neoplasm | 7.05e-04 | 134 | 154 | 5 | C0919267 | |
| Disease | reaction time measurement | MMS22L LRRC37A2 NLRP1 MSH3 CCNE1 ARHGAP1 KANSL1 RASGEF1B NGEF ADGRL2 EPAS1 | 7.06e-04 | 658 | 154 | 11 | EFO_0008393 |
| Disease | HDL cholesterol change measurement, response to simvastatin, response to fenofibrate | 7.42e-04 | 8 | 154 | 2 | EFO_0007805, GO_1901557, GO_1903491 | |
| Disease | Malignant neoplasm of ovary | 7.79e-04 | 137 | 154 | 5 | C1140680 | |
| Disease | neuroimaging measurement, brain volume measurement | 7.89e-04 | 286 | 154 | 7 | EFO_0004346, EFO_0006930 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 8.32e-04 | 139 | 154 | 5 | DOID:3908 (is_implicated_in) | |
| Disease | hippocampal CA3 volume | 8.77e-04 | 36 | 154 | 3 | EFO_0009395 | |
| Disease | plasma renin activity measurement | 9.51e-04 | 9 | 154 | 2 | EFO_0006828 | |
| Disease | N-acetylleucine measurement | 9.51e-04 | 9 | 154 | 2 | EFO_0800116 | |
| Disease | Congenital ocular coloboma (disorder) | 9.51e-04 | 9 | 154 | 2 | C0009363 | |
| Disease | brain volume measurement | MMS22L FAT3 KTN1 LRRC37A2 WNT4 FBXW8 KANSL1 VCAN CATSPERB AGBL2 | 1.18e-03 | 595 | 154 | 10 | EFO_0006930 |
| Disease | Kunitz-type protease inhibitor 2 measurement | 1.18e-03 | 10 | 154 | 2 | EFO_0008200 | |
| Disease | Congenital neurologic anomalies | 1.18e-03 | 10 | 154 | 2 | C0497552 | |
| Disease | Cranioschisis | 1.18e-03 | 10 | 154 | 2 | C0265541 | |
| Disease | carpal tunnel syndrome | 1.23e-03 | 89 | 154 | 4 | EFO_0004143 | |
| Disease | hippocampal CA4 volume | 1.28e-03 | 41 | 154 | 3 | EFO_0009396 | |
| Disease | retinal vasculature measurement | 1.64e-03 | 517 | 154 | 9 | EFO_0010554 | |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 1.68e-03 | 45 | 154 | 3 | DOID:3748 (is_implicated_in) | |
| Disease | Adenoid Cystic Carcinoma | 1.90e-03 | 100 | 154 | 4 | C0010606 | |
| Disease | myopathy (implicated_via_orthology) | 2.03e-03 | 48 | 154 | 3 | DOID:423 (implicated_via_orthology) | |
| Disease | thalamus volume change measurement | 2.36e-03 | 14 | 154 | 2 | EFO_0021496 | |
| Disease | Intellectual Disability | 2.49e-03 | 447 | 154 | 8 | C3714756 | |
| Disease | Squamous cell carcinoma of the head and neck | 2.55e-03 | 52 | 154 | 3 | C1168401 | |
| Disease | unipolar depression, response to escitalopram, response to citalopram, mood disorder | 2.72e-03 | 15 | 154 | 2 | EFO_0003761, EFO_0004247, EFO_0006329, EFO_0007871 | |
| Disease | heel bone mineral density, urate measurement | 2.73e-03 | 182 | 154 | 5 | EFO_0004531, EFO_0009270 | |
| Disease | breast cancer (is_marker_for) | 2.92e-03 | 185 | 154 | 5 | DOID:1612 (is_marker_for) | |
| Disease | amino acid measurement | 3.06e-03 | 678 | 154 | 10 | EFO_0005134 | |
| Disease | reticulocyte count | FLNB VWF COPB1 ACLY POTEF TMC6 ACTB MAP3K1 FAT1 KANSL1 MAST1 CHST12 PLA2G6 | 3.38e-03 | 1045 | 154 | 13 | EFO_0007986 |
| Disease | atopic asthma | 3.99e-03 | 199 | 154 | 5 | EFO_0010638 | |
| Disease | multiple sclerosis | 4.11e-03 | 594 | 154 | 9 | MONDO_0005301 | |
| Disease | osteochondrodysplasia (is_implicated_in) | 4.37e-03 | 19 | 154 | 2 | DOID:2256 (is_implicated_in) | |
| Disease | gut microbiome measurement, taxonomic microbiome measurement | 5.02e-03 | 66 | 154 | 3 | EFO_0007874, EFO_0007883 | |
| Disease | brain connectivity measurement | 5.17e-03 | 400 | 154 | 7 | EFO_0005210 | |
| Disease | white matter hyperintensity measurement | 5.20e-03 | 302 | 154 | 6 | EFO_0005665 | |
| Disease | Disorder of eye | 5.20e-03 | 212 | 154 | 5 | C0015397 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IHLEPLTPSEVLEYE | 916 | Q6N043 | |
| EQVTYHNPPLLFDLS | 496 | P54793 | |
| DDLELLYHIPEFIPE | 441 | Q6ZRH7 | |
| NYASIRLPEEHIPFF | 36 | Q5NDL2 | |
| TEVFYELAHELPLPH | 31 | Q99814 | |
| IHIQPFSLDAEQPDY | 101 | Q9H2F5 | |
| LDEIIFFAYVPENEP | 546 | Q9H7T0 | |
| ILPEFPDIIEIDLYH | 1371 | P13611 | |
| FYNELRVAPDEHPIL | 91 | Q562R1 | |
| EEVNHVISPLLDIYF | 246 | O14977 | |
| TYQPYLIQPEDLRDH | 186 | P35670 | |
| YNELRVAPEEHPILL | 91 | Q9BYX7 | |
| YNELRVAPEEHPVLL | 91 | P60709 | |
| YNELRVAPEEHPVLL | 91 | P63261 | |
| HPYEVAEVIALPVEQ | 141 | O60888 | |
| LPEEAEAYLLQILPH | 476 | Q8WXG9 | |
| DLHEVLLPQYPQQIF | 261 | P24864 | |
| EITEEPPYIHFLNTF | 296 | Q9BR76 | |
| VLFTLPHIDPDNYFN | 771 | O95490 | |
| FYNELRVAPEEHPTL | 91 | P63267 | |
| ALVHLSLVPPAEELY | 561 | Q3MIX3 | |
| HCSEVELPYPDLQEF | 341 | Q01433 | |
| EFIPVHNLENLESLY | 141 | Q99467 | |
| ESHLDTPYNVPDVVI | 286 | O14874 | |
| EFLINDYTHNIPLID | 1146 | Q16720 | |
| PDVHYSFNIPLEERS | 831 | P59510 | |
| KLPYDVTPEQALAHE | 1111 | P46940 | |
| ESAYPNAELVFLEIH | 361 | Q13613 | |
| EFPHVIEIYDFPQEF | 641 | Q7Z5L2 | |
| QTVFQEVFEPPHYEL | 381 | Q8TDF5 | |
| RELEEPLIPHEFYEQ | 971 | Q9C0H5 | |
| PFHINIYPLAVLFED | 771 | Q4ADV7 | |
| AIIDPLIYAFHSQEL | 291 | Q01726 | |
| EHVLAYFLPEAPAEL | 241 | P49736 | |
| REILLYFFPEHQLPS | 826 | Q86VD1 | |
| PSFYHLSEIVENLLP | 941 | P16234 | |
| LDYPPDRVTLFLHNN | 321 | O60568 | |
| INVIAPLDFEAHPAY | 2236 | Q14517 | |
| DYFPIHLIKTQDLDP | 86 | Q96PD6 | |
| QPPLYHLREVEAQIY | 156 | Q5HYI7 | |
| VILEIPELLSPVEHY | 671 | P20585 | |
| VDLYRSHIPLAFDPT | 1621 | Q9Y618 | |
| YNELRVAPEEHPVLL | 791 | A5A3E0 | |
| LEETVEAAIHPPYLV | 1206 | Q96RG2 | |
| LNHNPLTTVEDPYLF | 971 | O60309 | |
| DSLELEPTYNPLHVQ | 431 | Q8TC57 | |
| LNHNPLTTVEDPYLF | 971 | A6NM11 | |
| LNHNPLTTVEDPYLF | 971 | A6NMS7 | |
| LQLEVLTAEPPEHYS | 941 | Q6ZRS4 | |
| FLQELTEPVIPFHLY | 626 | Q9P107 | |
| TEPVIPFHLYDAFIS | 631 | Q9P107 | |
| VHPYEALEAQLPSVL | 156 | Q6ZRQ5 | |
| PVNVVEFHPNEYLLA | 191 | Q9BVA0 | |
| DVPFFDIQLPYELAI | 111 | Q8N3Y1 | |
| LHVVEVTYDDVPIPN | 1301 | O75369 | |
| FNDEHIPESPYLVPV | 2266 | O75369 | |
| EIPDINLDVPHSYSV | 411 | Q53EL6 | |
| DEFPLAHLLEPFRQY | 416 | Q8N8D1 | |
| EPIEPNFFTADYHLL | 1091 | Q6ZWH5 | |
| LEDYLPVFLNTEHSV | 3211 | Q9NYQ8 | |
| YTLEPLHVLLDSQDP | 341 | P14222 | |
| SPLDAPQLLHFVDQY | 1371 | Q9C000 | |
| TIYRNFEHLIPDAPE | 161 | P53618 | |
| CVPLEPFDEDYLNHL | 141 | Q8TAT6 | |
| PEIHYEAPLLERLSQ | 646 | Q7Z3B3 | |
| DEVPVELYTAFQHTP | 196 | Q8IZD2 | |
| VFVDEPLIHATTYIP | 221 | Q86UP2 | |
| DDIYVIPQPHFSTDQ | 1461 | Q8NG31 | |
| LDILQPPHIDYFEEI | 201 | Q9UBE8 | |
| LIQHLVPNVDYYPDR | 46 | Q0VAM2 | |
| HVLETFYPISPIIDL | 251 | Q9BZE1 | |
| VDSRVDHLFPPSLYI | 11 | P46093 | |
| ERLHQLPYQPTVDEL | 116 | Q9Y2H9 | |
| LDAYVFNTEAHPLPI | 681 | Q9UKM7 | |
| IELPSTIYEALHLPD | 656 | O43422 | |
| YNELRVAPEEHPILL | 791 | Q6S8J3 | |
| IPVHTVPLSEDQLLY | 141 | P15309 | |
| SDLLAQFHYPRDPLI | 641 | A1KZ92 | |
| AYLEVDLPQPLSTHL | 61 | P49619 | |
| HPSEDEILAQYLVPA | 2731 | P42858 | |
| FSQQLEHLLTPPERY | 396 | A4D2P6 | |
| RLPLLHPNYFVQTVE | 256 | Q6TFL4 | |
| ELYHTDFRPVPLLES | 281 | O75417 | |
| VVDVNENLHTPYFPD | 1031 | Q8TDW7 | |
| ETHLKQTIPDPYEDF | 6 | Q5U5Z8 | |
| VFYREALHIPPEELS | 311 | Q674R7 | |
| YIHIIQSLPDDDLPE | 3076 | Q0VDD8 | |
| VDVPEFLVYFPLLNE | 366 | O43148 | |
| IPYSPDVQIHAERFI | 896 | Q8N766 | |
| QEQYIHPLPLDTECI | 766 | Q6PJP8 | |
| DADYIAAFLHVLLPV | 316 | Q9UBN7 | |
| PYPLFQSHVEDLYVE | 386 | P78347 | |
| YILIPSTFEPHQEAD | 466 | O14815 | |
| DLIIYFEPPSEDLQH | 446 | P21817 | |
| LVDFHSLPEPERNYN | 906 | P21817 | |
| SHVLPEFLLEPEDYK | 1646 | Q6ZTR5 | |
| HLASPVQESPFYVLI | 326 | Q8N465 | |
| PSSVTEDLYIHFQPI | 231 | Q9H756 | |
| IILHPNYDPILLDAD | 546 | Q6UXH9 | |
| LSLVPHYDILEPEEL | 241 | Q53GL7 | |
| IHEDVFPEPQARFYV | 651 | Q6P5Z2 | |
| QDLHYFPFRPSDLIV | 176 | O14832 | |
| VLNFLLYVPELAHSP | 321 | Q96S52 | |
| LYVPELAHSPLYIQD | 326 | Q96S52 | |
| IDRLLLEFPAEFYPH | 761 | Q13233 | |
| HYLFRVPQPDSLDSL | 336 | A6NKG5 | |
| ENFHFPVPYEELADR | 296 | Q5T7P8 | |
| TEEFPLIDQTFYPNH | 241 | P17600 | |
| VAIVEPSERHFYQPI | 71 | Q9Y6N5 | |
| YFHPQKLSPEELAEL | 331 | Q8IZ69 | |
| HEQPLLVGIFLDYEA | 406 | O00635 | |
| NILRIYNLPPELYHE | 191 | Q9BUR4 | |
| AVTPAEPYARVLFHL | 131 | Q24JP5 | |
| RIFDVQLPHYSPSDE | 106 | Q16647 | |
| SHQDYIPVLLLVDDF | 791 | Q8IVG5 | |
| DYISPLLNFAAEHVP | 151 | Q9Y227 | |
| HPYVAQQPDELTLEL | 621 | Q8N5V2 | |
| LPVDFDQYNELHLPA | 301 | Q07960 | |
| PEQQRYSLFLPLHEL | 91 | O95707 | |
| PSSEPHLIFVYEDRQ | 646 | O75182 | |
| ELEHSVPLLEVYPVE | 226 | Q9BZQ2 | |
| YNELRVAPEEHPILL | 791 | P0CG38 | |
| LLPFYESSPQVLHTE | 91 | O60733 | |
| PEYENFRHLLQAPVD | 676 | Q15436 | |
| TYALQFHVPAEIIIP | 341 | Q495N2 | |
| PTLFDLFAELEDYHP | 421 | Q8TDI8 | |
| LIEPFVPHSQAEEFY | 106 | P53396 | |
| QHFPATPLLDYALEV | 996 | P53396 | |
| LSHIDPDVLYPSLNV | 191 | Q9H553 | |
| PEEEHPSVTLFRQYL | 6 | Q03154 | |
| LPNYLDVATFLHVNP | 651 | Q8N3C0 | |
| YVLEHFITPLPEDHL | 201 | Q7LGC8 | |
| VAYLIDPHTQREEPF | 241 | Q9NPF2 | |
| YLLDPHTEKLAPFNE | 306 | Q9NRB3 | |
| LQHEELLPKYPDFSI | 171 | Q8WW14 | |
| TAVDLPPEFIHLYIS | 416 | Q9UKZ1 | |
| VLVFYHSPVALEVPF | 191 | Q63HM9 | |
| SFLEPYLRNELAHPV | 921 | O75762 | |
| EHIYDFPPLSEELIS | 191 | Q13432 | |
| TLYVEDISEPPLHDF | 1256 | P04275 | |
| FTLDYPHVQIPFEIT | 71 | Q9UBY0 | |
| ERFSLIYSEHPFIVP | 151 | O43280 | |
| LPPSHTQYDFVELLD | 436 | Q9P273 | |
| HLNEIGFIPDLYAIP | 611 | Q8TEA7 | |
| QSLLQHFPDILPLEY | 231 | P49638 | |
| VEEAVILTYFPVVHP | 51 | O95859 | |
| IYELLHQPNPFEVRA | 1261 | Q86YV5 | |
| PLTFDVNNPLHLDYV | 751 | P22314 | |
| LFPPDESIDLYQVIH | 491 | Q96MU7 | |
| YPIILSFENHVDSPR | 401 | Q00722 | |
| LPPHYDDVEVFILQL | 176 | Q8IUF8 | |
| HLFPDEYIPEDILKN | 126 | Q9BYD1 | |
| DLLPHFLVEPEDVYI | 41 | Q6ZN44 | |
| LPHNIIELDVRAYVP | 736 | P78527 | |
| VPHIEENRYLFPEVD | 576 | Q6PKC3 | |
| QPEVPILYHDVTSLL | 1526 | Q6ZT12 | |
| QFKPHTDEDLVYLEP | 261 | P56705 | |
| LEPHDSPVLEVYVAI | 496 | Q7Z403 | |
| SLPVAPAYHVIEFEL | 866 | P48553 | |
| PAYHVIEFELEVLSL | 871 | P48553 | |
| VNPVLFPNREDYIHL | 221 | Q9BUB7 | |
| LQPDFLYDHIQPVRA | 856 | Q9Y4A5 | |
| VPQEEVPFRYHELIT | 311 | Q5QJ74 | |
| IFPDHYEIALPNIEE | 141 | Q92995 | |
| YSFQEEEPVLDPHLA | 271 | Q92995 | |
| HILPQTFLLPAEYAE | 151 | Q6EMB2 | |
| EVHIIELITPNSNPY | 231 | Q03167 | |
| TLHDPRYVFATLLDP | 996 | O75132 | |
| AVINLDPFTRVHPYE | 4026 | Q5THJ4 | |
| PFIHPSYLLNVVDNE | 526 | Q96CT2 |